Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Telomerase Deletion Limits Progression of p53-Mutant Hepatocellular Carcinoma With Short Telomeres in Chronic Liver Disease

27 Jan 2007

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related Molecular Pathways
Share to Clusterin in disease pathology
Share to Telomeres, Telomerase, and Senescence

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 17433324
DOI: 10.1053/j.gastro.2007.01.045

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Telomerase Deletion Limits Progression of p53-Mutant Hepatocellular Carcinoma With Short Telomeres in Chronic Liver DiseasePMID 17433324Read ↗

Telomerase activity and telomere length in hepatocellular carcinoma and chronic liver diseaseSemantic proximity Read ↗

Progressive telomere shortening and telomerase reactivation during hepatocellular carcinogenesisSemantic proximity Read ↗

Telomeres and telomerase: new targets for the treatment of liver cirrhosis and hepatocellular carcinomaSemantic proximity Read ↗

Telomere shortening and telomerase reactivation in dysplastic nodules of human hepatocarcinogenesisSemantic proximity Read ↗

Telomere Shortening in Chronic Liver DiseasesSemantic proximity Read ↗

Telomeres and telomerase: A dual role in hepatocarcinogenesisSemantic proximity Read ↗

Telomerase: a good target in hepatocellular carcinoma? An overview of relevant preclinical dataSemantic proximity Read ↗

Telomere length is key to hepatocellular carcinoma diversity and telomerase addiction is an actionable therapeutic targetSemantic proximity Read ↗

Control of Cellular Aging, Tissue Function, and Cancer by p53 Downstream of Telomeres.Semantic proximity Read ↗

Telomeres, NAFLD and Chronic Liver Disease.Semantic proximity Read ↗

Cooperative interactions of p53 mutation, telomere dysfunction, and chronic liver damage in hepatocellular carcinoma progression.Semantic proximity Read ↗

Telomere biology and telomerase mutations in cirrhotic patients with hepatocellular carcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.